Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.45B |
| 2 |
Apple
AAPL
|
+$814M |
| 3 |
NVIDIA
NVDA
|
+$700M |
| 4 |
Broadcom
AVGO
|
+$647M |
| 5 |
Shopify
SHOP
|
+$593M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$701M |
| 2 |
Johnson & Johnson
JNJ
|
+$685M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$484M |
| 4 |
Meta Platforms (Facebook)
META
|
+$407M |
| 5 |
HubSpot
HUBS
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.47% |
| 2 | Financials | 12.85% |
| 3 | Industrials | 11.86% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Alvotech
ALVO
$1.28B
| $295K | ﹤0.01% |
32,398
+8,794
| +37% | +$82.6K |
|
3302
Monte Rosa Therapeutics
GLUE
$1.35B
| $295K | ﹤0.01% |
65,389
+30,043
| +85% | +$134K |
|
3303
Gossamer Bio
GOSS
$86.1M
| $294K | ﹤0.01% |
239,245
+195,548
| +448% | +$213K |
|
3304
Nokia
NOK
$51B
| $293K | ﹤0.01% |
56,548
-4,268
| -7% | -$22K |
|
3305
BTCS Inc
BTCS
$56.2M
| $293K | ﹤0.01% |
+133,002
| New | +$282K |
|
3306
Sierra Bancorp
BSRR
$516M
| $293K | ﹤0.01% |
9,852
+1,177
| +14% | +$32K |
|
3307
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.3B
| $292K | ﹤0.01% |
3,000
| – | – |
|
3308
NRC Health Common Stock
NRC
$462M
| $292K | ﹤0.01% |
17,368
+1,022
| +6% | +$13.8K |
|
|
EFXT
3309
Enerflex
EFXT
$2.5B
| $289K | ﹤0.01% |
36,669
-9,275
| -20% | -$66.4K |
|
3310
Grayscale Bitcoin Trust
GBTC
$9.61B
| $289K | ﹤0.01% |
3,408
-816
| -19% | -$63.5K |
|
3311
MeiraGTx Holdings
MGTX
$1.21B
| $288K | ﹤0.01% |
44,153
-306,248
| -87% | -$1.81M |
|
3312
Kodiak Sciences
KOD
$2.72B
| $287K | ﹤0.01% |
76,866
-4,126
| -5% | -$14.6K |
|
3313
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.6B
| $286K | ﹤0.01% |
2,611
+99
| +4% | +$10.6K |
|
3314
Fate Therapeutics
FATE
$322M
| $286K | ﹤0.01% |
255,372
+41,869
| +20% | +$48.7K |
|
3315
Red River Bancshares
RRBI
$663M
| $286K | ﹤0.01% |
4,868
-1,024
| -17% | -$55.5K |
|
3316
LifeVantage
LFVN
$84.3M
| $285K | ﹤0.01% |
+21,783
| New | +$282K |
|
|
NEXN
3317
Nexxen International
NEXN
$599M
| $285K | ﹤0.01% |
+27,351
| New | +$278K |
|
|
REFI
3318
Chicago Atlantic Real Estate Finance
REFI
$260M
| $284K | ﹤0.01% |
20,376
+7,758
| +61% | +$111K |
|
3319
FRP Holdings
FRPH
$415M
| $284K | ﹤0.01% |
10,574
-1,751
| -14% | -$47.5K |
|
3320
Definitive Healthcare
DH
$73.7M
| $284K | ﹤0.01% |
72,900
+11,029
| +18% | +$34.7K |
|
3321
Nature's Sunshine
NATR
$277M
| $284K | ﹤0.01% |
19,204
-1,652
| -8% | -$22.3K |
|
|
ONIT
3322
Onity Group
ONIT
$326M
| $283K | ﹤0.01% |
+7,409
| New | +$262K |
|
3323
Utah Medical Products
UTMD
$227M
| $282K | ﹤0.01% |
4,955
+1,253
| +34% | +$68.1K |
|
3324
Seer Inc
SEER
$119M
| $282K | ﹤0.01% |
131,708
-58,394
| -31% | -$117K |
|
3325
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.78B
| $282K | ﹤0.01% |
11,105
-731
| -6% | -$17.9K |
|
Similar funds
Invesco's Q2 2025 Portfolio in Review
As of Q2 2025, Invesco held 3,922 positions worth $588B, up 11% from $528B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Invesco's Q2 2025 filing shows 165 new, 1,670 increased, 1,835 reduced and 165 closed positions. Its largest new stake was QXO Inc: 27,561,664 shares worth $594M. The largest sale was UnitedHealth, an estimated $701M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q2 2025 buy was QXO Inc: 27,561,664 shares worth $594M.
- Invesco added most to Microsoft in Q2 2025, an estimated $1.45B increase.
- Invesco's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $701M.
- Invesco fully exited Discover Financial Services in Q2 2025, selling an estimated $484M.
- Invesco's ten largest holdings make up 20% of its $588B portfolio in Q2 2025.
- Invesco opened 165 new positions and closed 165 in Q2 2025.
- Invesco's portfolio value rose 11% quarter-over-quarter to $588B.
Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.